News summary

Associations of obesity and visceral adiposity with overall survival and immune-related adverse events in patients with endometrial cancer treated with immunotherapy: a retrospective analysis

Source: Frontiers - Health • Published: 09 Nov 2026, 00:00

Summarized by Masters of Longevity from Frontiers - Health.

In 338 ICI-treated endometrial cancer patients, visceral fat was linked to mortality and irAEs.

Associations of obesity and visceral adiposity with overall survival and immune-related adverse events in patients with endometrial cancer treated with immunotherapy: a retrospective analysis
Key Takeaways
  • Visceral adipose tissue was associated with higher mortality.
  • BMI category and subcutaneous fat were not linked to survival.
  • Visceral adipose tissue was associated with earlier immune adverse events.
Read the full article at Frontiers - Health ↗

Continue exploring

Recommended MoL Picks

MoL PickCreatine and Cancer: Why New Mouse Studies Point in Opposite DirectionsCreatine strengthened antitumour immune cells in one mouse study—and promoted metastasis through platelets in another. The apparent contradiction reveals why neither result is a supplement recommendation.MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?